CYN vs REGN · rev $249.0K vs P/E 14, rev $4.29B
Cyngn Inc (CYN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Cyngn Inc (CYN) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CYN revenue for 2026-06-30 was $249.0K. Net income was -$12.8M. CYN currently screens at market cap $23.8M.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CYN currently screens at market cap $23.8M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CYN and REGN stock pages for the full models.
Not investment advice.